Your browser doesn't support javascript.
loading
Imatinib Pharmacokinetics in a Large Observational Cohort of Gastrointestinal Stromal Tumour Patients.
Farag, Sheima; Verheijen, Remy B; Martijn Kerst, J; Cats, Annemiek; Huitema, Alwin D R; Steeghs, Neeltje.
Afiliación
  • Farag S; Department of Medical Oncology and Clinical Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. s.farag@nki.nl.
  • Verheijen RB; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands.
  • Martijn Kerst J; Department of Medical Oncology and Clinical Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Cats A; Department of Gastroenterology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Huitema AD; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands.
  • Steeghs N; Department of Medical Oncology and Clinical Pharmacology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Clin Pharmacokinet ; 56(3): 287-292, 2017 03.
Article en En | MEDLINE | ID: mdl-27435281

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tumores del Estroma Gastrointestinal / Mesilato de Imatinib / Neoplasias Gastrointestinales / Antineoplásicos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Clin Pharmacokinet Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tumores del Estroma Gastrointestinal / Mesilato de Imatinib / Neoplasias Gastrointestinales / Antineoplásicos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Clin Pharmacokinet Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza